FOEHR MATTHEW W

Average Profitability
25.1%
Insider Buys Quantity
23
Insider Buys Sum
$6.89M
Insider Sells Quantity
15
Insider Sells Sum
$13.49M

Insider Activity of FOEHR MATTHEW W

According to the SEC Form 4 filings, FOEHR MATTHEW W, being in a position of

  1. President and CEO at OmniAb, Inc.,
    оver the last 12 months, has bought 465000 shares for $2.23M, and sold 13634 shares for $56,308,
    over all time since 2023-05-12, has bought 1360000 shares for $5.91M, and sold 13634 shares for $56,308.

The largest purchase of all time was on 2023-05-12 and amounted to 440000 shares of OmniAb, Inc. for $1.5M.

The largest sale of all time was on 2018-10-01 and amounted to 12000 shares of Ligand Pharmaceuticals Incorporated for $3.29M.

Biography of FOEHR MATTHEW W

No biography is available at this moment.

2024-12-09SaleOmniAb, Inc.
OABI
President and CEO
13,634
0.0113%
$4.13$56,308-6.65%
2024-05-24PurchaseOmniAb, Inc.
OABI
President and CEO
240,000
0.2109%
$4.42$1.06M-5.13%
2024-03-22PurchaseOmniAb, Inc.
OABI
President and CEO
225,000
0.1948%
$5.19$1.17M-16.02%
2023-12-12PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
200,000
0.1722%
$5.05$1.01M-8.93%
2023-11-10PurchaseOmniAb, Inc.
OABI
President and CEO
95,000
0.0821%
$4.27$405,517+9.31%
2023-08-14PurchaseOmniAb, Inc.
OABI
President and CEO
45,000
0.0391%
$5.48$246,600-6.79%
2023-06-09PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
115,000
0.1157%
$4.52$519,800+14.35%
2023-05-12PurchaseOmniAb, Inc.
OABI
Chief Executive Officer
440,000
0.4311%
$3.40$1.5M+48%
2022-05-13PurchaseLigand Pharmaceuticals Incorporated
LGND
President and COO
2,500
0.0143%
$82.76$206,910+21.81%
2022-05-02PurchaseViking Therapeutics, Inc.
VKTX
90,000
0.1144%
$2.47$222,390+53.75%
2021-06-10PurchaseViking Therapeutics, Inc.
VKTX
director
40,000
0.052%
$5.69$227,600-11.57%
2020-06-30SaleViking Therapeutics, Inc.
VKTX
director
26,000
0.0365%
$7.35$191,100-12.83%
2018-10-01SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
12,000
0.0573%
$273.88$3.29M-56.27%
2018-09-04SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
12,000
0.056%
$255.01$3.06M-52.36%
2018-08-17PurchaseQualigen Therapeutics, Inc.
QLGN
director
19,751
0.0067%
$2.04$40,292-53.31%
2018-05-10SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
8,881
0.0409%
$167.63$1.49M-5.11%
2018-02-23SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
5,444
0.0255%
$152.98$832,824+11.33%
2017-08-09SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
6,100
0.0023%
$9.97$60,817+21.97%
2017-05-18PurchaseQualigen Therapeutics, Inc.
QLGN
director
18,000
0.0006%
$0.62$11,155-45.98%
2017-05-12SaleLigand Pharmaceuticals Incorporated
LGND
President and COO
5,621
0.0024%
$9.97$56,041+22.53%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.